Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia

Blood

Volumn 117, Issue 23, 2011, Pages 6247-6254

  Van Delft, Frederik W ^a   Horsley, Sharon ^a   Colman, Sue ^a   Anderson, Kristina ^a   Bateman, Caroline ^a   Kempski, Helena ^b   Zuna, Jan ^c   Eckert, Cornelia ^d   Saha, Vaskar ^e   Kearney, Lyndal ^a   Ford, Anthony ^a   Greaves, Mel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c CHARLES UNIVERSITY   (Czech Republic)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CELL CYCLE; CHILD; CHROMOSOME 16; CLINICAL ARTICLE; COPY NUMBER VARIATION; GENE DELETION; GENOTYPE; HUMAN; LEUKEMIA RELAPSE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 79959463542     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-314674     Document Type: Article

References (48)

1. Harrison CJ, Moorman AV, Barber KE, et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol. 2005;129(4):520-530. (Pubitemid 40769901)
2. Jabber Al-Obaidi MS, Martineau M, Bennett CF, et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia. 2002;16(4): 669-674. (Pubitemid 34449749)
3. Ford AM, Bennett CA, Price CM, Bruin MC, Van Wering ER, Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A. 1998;95(8): 4584-4588. (Pubitemid 28207956)
4. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3(9):639-649. (Pubitemid 37328819)
5. Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood. 1999;94(3):1057-1062. (Pubitemid 29361838)
6. Mori H, Colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A. 2002;99(12):8242-8247. (Pubitemid 34651037)
7. Tsuzuki S, Seto M, Greaves M, Enver T. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Proc Natl Acad Sci U S A. 2004; 101(22):8443-8448. (Pubitemid 38736594)
8. Hong D, Gupta R, Ancliff P, et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science. 2008; 319(5861):336-339.
9. O'Connor HE, Butler TA, Clark R, et al. Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis. Leukemia. 1998;12(7):1099-1106. (Pubitemid 28349806)
10. Schultz KR, Pullen DJ, Sather HN, et al. Riskand response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood. 2007;109(3): 926-935. (Pubitemid 46220635)
11. Seeger K, von Stackelberg A, Taube T, et al. Relapse of TEL-AML1-positive acute lymphoblastic leukemia in childhood: a matched-pair analysis. J Clin Oncol. 2001;19(13):3188-3193. (Pubitemid 32591435)
12. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood. 1997; 90(12):4933-4937. (Pubitemid 28007208)
13. Konrad M, Metzler M, Panzer S, et al. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood. 2003;101(9):3635- 3640. (Pubitemid 36857953)
14. Forestier E, Heyman M, Andersen MK, et al. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL- 1992 protocol: frequent late relapses but good overall survival. Br J Haematol. 2008;140(6):665-672. (Pubitemid 351300921)
15. Chow CD, Dalla-Pozza L, Gottlieb DJ, Hertzberg MS. Two cases of very late relapsing ALL carrying the TEL:AML1 fusion gene. Leukemia. 1999;13(11): 1893-1894. (Pubitemid 29535276)
16. Vora A, Frost L, Goodeve A, et al. Late relapsing childhood lymphoblastic leukemia. Blood. 1998; 92(7):2334-2337. (Pubitemid 28452974)
17. Chessells JM. Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol. 1998;102(2):423-438. (Pubitemid 28346583)
18. Lawson SE, Harrison G, Richards S, et al. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol. 2000;108(3):531-543. (Pubitemid 30196250)
19. Ford AM, Fasching K, Panzer-Grumayer ER, Koenig M, Haas OA, Greaves MF. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood. 2001;98(3):558-564.
20. Zuna J, Ford AM, Peham M, et al. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Clin Cancer Res. 2004;10(16):5355-5360. (Pubitemid 39100471)
21. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137):758-764. (Pubitemid 46582031)
22. Mullighan CG, Phillips LA, Su X, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008; 322(5906):1377-1380. (Pubitemid 352775249)
23. Panzer-Grumayer ER, Cazzaniga G, van der Velden VH, et al. Immunogenotype changes prevail in relapses of young children with TEL-AML1- positive acute lymphoblastic leukemia and derive mainly from clonal selection. Clin Cancer Res. 2005;11(21):7720-7727. (Pubitemid 41611614)
24. Yang JJ, Bhojwani D, Yang W, et al. Genomewide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood. 2008; 112(10):4178-4183.
25. Kuster L, Grausenburger R, Fuka G, et al. ETV6/ RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling. Blood. 2011;117(9):2658-2667.
26. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using highdensity oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 2005; 65(14):6071-6079. (Pubitemid 40994391)
27. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A. 2001;98(1):31-36. (Pubitemid 32095858)
28. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-ofheterozygosity data. Bioinformatics. 2004;20(8): 1233-1240. (Pubitemid 38807579)
29. Buckle VJ, Rack K. Fluorescent in situ hybridisation. In: Davies KE, ed. Human Genetic Analysis. Oxford, United Kingdom: IRL Press; 1993:59-82.
30. von Goessel H, Jacobs U, Semper S, et al. Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia. Leuk Res. 2009;33(8):1082-1088.
31. Kawamata N, Ogawa S, Seeger K, et al. Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia. Int J Oncol. 2009;34(6): 1603-1612.
32. Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood. 2008;111(2):776-784.
33. Kuiper RP, Schoenmakers EF, van Reijmersdal SV, et al. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia. 2007;21(6):1258-1266. (Pubitemid 46831815)
34. Lilljebjorn H, Soneson C, Andersson A, et al. The correlation pattern of acquired copy number changes in 164 ETV6/RUNX1-positive childhood acute lymphoblastic leukemias. Hum Mol Genet. 2010;19(16):3150-3158.
35. Huppi K, Volfovsky N, Runfola T, et al. The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res. 2008;6(2):212-221. (Pubitemid 351342409)
36. Schiffman JD, Hodgson JG, VandenBerg SR, et al. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res. 2010; 70(2):512-519.
37. Guan Y, Kuo WL, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007; 13(19):5745-5755. (Pubitemid 47583899)
38. Storlazzi CT, Fioretos T, Paulsson K, et al. Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies. Hum Mol Genet. 2004;13(14):1479-1485. (Pubitemid 39023056)
39. Choi S, Henderson MJ, Kwan E, et al. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood. 2007;110(2):632-639. (Pubitemid 47105402)
40. Ly-Sunnaram B, Henry C, Gandemer V, et al. Late ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis. Leuk Res. 2005;29(9):1089-1094. (Pubitemid 40982605)
41. Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, Hickstein DD. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2006; 103(41):15166-15171. (Pubitemid 44583182)
42. Anderson K, Lutz C, van Delft FW, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011;469(7330):356-361.
43. Greaves M. Darwin and evolutionary tales in leukemia. The Ham-Wasserman Lecture. Hematology Am Soc Hematol Educ Program. 2009;3-12.
44. Henderson MJ, Choi S, Beesley AH, et al. Mechanism of relapse in pediatric acute lymphoblastic leukemia. Cell Cycle. 2008;7(10):1315-1320. (Pubitemid 351872566)
45. Komarova NL, Wodarz D. Drug resistance in cancer: principles of emergence and prevention. Proc Natl Acad Sci U S A. 2005;102(27):9714-9719. (Pubitemid 40981746)
46. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102(7):2321-2333. (Pubitemid 37193565)
47. Maia AT, Ford AM, Jalali GR, et al. Molecular tracking of leukemogenesis in a triplet pregnancy. Blood. 2001;98(2):478-482.
48. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A. 1997;94(25):13950-13954. (Pubitemid 28009690)